Clinical Trials Logo

Filter by:
NCT ID: NCT05901571 Not yet recruiting - Clinical trials for Depressive Disorder, Major

Acupuncture and Escitalopram for Treating Major Depression Clinical Study

AE-TMDCS
Start date: September 2023
Phase: N/A
Study type: Interventional

We will be able to investigate in a sample of patients free of antidepressants whether acupuncture is more effective than placebo.

NCT ID: NCT05901558 Recruiting - Clinical trials for Autism Spectrum Disorder

Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD

Start date: June 15, 2023
Phase: N/A
Study type: Interventional

The project aims to develop and implement the Strategies for Toddler Autism spectrum disorder(ASD) with Remote-therapy (STAR) model for early toddlers with ASD in local community sites in Shanghai. It's a randomized control trial lasting 3 years. The children will be divided into 2 groups, one for STAR intervention group and the other for community intervention group. The STAR intervention group will be performed STAR other than community intervention.

NCT ID: NCT05901480 Recruiting - DFNB9 Clinical Trials

An Investigator Initiated Study for OTOV101N+OTOV101C Injection

Start date: June 26, 2023
Phase: N/A
Study type: Interventional

This study is an investigator initiated study to evaluate the safety, tolerability, and efficacy of OTOV101N+OTOV101C injection in treating patients with OTOF mutation-related deafness. The enrolled subjects who meet the inclusion and exclusion criteria will receive the gene therapy of OTOV101N+OTOV101C injection via intracochlear injection. All participants will return to the hospital for safety and efficacy evaluations at predetermined time points defined by protocol during the study (Week 1 ± 1 Day, Week 2 ± 3 Days, Week 3 ± 3 Days, Month 1 ± 3 Days, Month 2 ± 3 Days, Month 4 ± 6 Days, Month 6 ± 6 Days, Month 9 ± 6 Days, Month 12 ± 6 Days/EOS (end of study)/unscheduled visit).

NCT ID: NCT05901441 Completed - Analgesia Clinical Trials

Effect of Epidural Hydromorphone Combined With Ropivacaine in Labor Analgesia

Start date: June 1, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the effects of three different doses of hydromorphone combined with ropivacaine and sufentanil combined with ropivacaine in epidural labor analgesia through prospective clinical trials, so as to explore whether hydromorphone combined with ropivacaine has advantages in epidural labor analgesia, and find out the optimal dose of hydromorphone. Participants will be randomly allocated to four groups: H1 group,H2 group,H3 group and SF group.For those in H1 group: they will be administered with15 ug/ml hydromorphone and 0.08% ropivacaine for epidural labor analgesia, For those in H2 group: they will be administered with17.5 ug/ml hydromorphone and 0.08% ropivacaine for epidural labor analgesia, For those in H3 group: they will be administered with 20 ug/ml hydromorphone and 0.08% ropivacaine for epidural labor analgesia, For those in SF group: they will be administered with 40 ug/ml sufentanil and 0.08% ropivacaine for epidural labor analgesia. The goal of this clinical trial is to provide a new treatment option for pregnant women in epidural labor analgesia, and to provide a basis for hydromorphone combined with ropivacaine in epidural labor analgesia.

NCT ID: NCT05901428 Recruiting - Clinical trials for Hormone Receptor Positive HER-2 Negative Breast Cancer

TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

Start date: June 1, 2023
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of docetaxel plus carboplatin (TCb) regimen compared with conventional chemotherapy regimen (epirubicin plus cyclophosphamide followed by docetaxel, EC-T) regimen as adjuvant chemotherapy in patients with early-stage high-risk estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER2) negative (ER+/HER2-) breast cancer.

NCT ID: NCT05901415 Recruiting - Anesthesia, Local Clinical Trials

Modified LPB and SPB vs Classical LPB and SPB

Start date: August 14, 2023
Phase: N/A
Study type: Interventional

The timing of surgery for hip fractures is crucial for elderly patients. The mortality rate for elderly patients after hip fracture is high, and anesthetic decisions significantly affect the patient's outcome. Regional anesthesia has been shown to have better outcomes than general anesthesia. We proposed a newly developed modified position for the ultrasound-guided combined anterior lumbar and lateral sacral plexus block technique that offers benefits, including minimizing interference with circulation and anesthesia, avoiding position change and pain, and providing effective postoperative analgesia.

NCT ID: NCT05901402 Recruiting - Clinical trials for Aerobic and Resistance Exercise

Application of Aerobic and Resistance Exercise in Blood Glucose Control in Pregnant Women With GDM

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Objective:The aim of this study was to explore the rationality and clinical value of aerobic exercise during pregnancy in blood glucose control of pregnant women with GDM, and to provide theoretical basis for more appropriate clinical exercise management. Method:The subjects of gestational diabetes in the hospital from March 2023 to May 2024 were studied. The exercise exercise with daily responsible nurses was based on resistance exercise, mainly with upper limb muscle exercise, supplemented by lower limb muscle exercise and aerobic exercise. Fasting blood glucose, 2 hours postprandial blood glucose and HbA1c in pregnant women with GDM were monitored.

NCT ID: NCT05901350 Completed - Parkinson Disease Clinical Trials

The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Patients with parkinson disease (PD) usually reduced the dose the levodopa after received deep brain stimulation (DBS). However, studies seldomly mentioned about the influences on non-motors systems after the reduction. Our study focused on the changes after DBS and attribute them to the levodopa variety.

NCT ID: NCT05901051 Completed - Clinical trials for Helicobacter Pylori Infection

High-dose Dual Therapy With Different Administration Frequencies

Start date: March 30, 2021
Phase: Phase 4
Study type: Interventional

This study is a single center, randomized controlled clinical study. The enrolled patients are HP positive. They are diagnosed as HP positive by rapid urease test and/or 13C urea breath test. According to the declaration of Helsinki, 327 patients will be included in this study. After obtaining the written informed consent of the patients, HP culture and drug sensitivity test will be conducted on all the selected patients with the success rate, adverse reactions, compliance, antibiotic resistance of HP and its impact on HP eradication.

NCT ID: NCT05900882 Recruiting - Multiple Myeloma Clinical Trials

SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease

Start date: July 15, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of SVRd in NDMM patients presenting with extramedullary disease.